Singapore Paincare's (SGX:FRQ) attributable profit for the six months ended Dec. 31, 2024, declined 53% to SG$453,000 from SG$969,000 a year earlier, according to a Friday filing with the Singapore Exchange.
Earnings per share dropped to SG$0.0026 compared with SG$0.0057 in the comparable period.
Revenue was up 2.8% year over year to SG$13.7 million from SG$13.4 million, driven by increased revenue from specialist clinics.
Shares of the health and medical treatment company were down over 3% in recent trading.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。